Aquestive Therapeutics, Inc. (AQST) Q1 2026 Earnings Call Transcript
Aquestive Therapeutics Inc AQST
$4.04
▲ +1.00%
(+$0.04)
Open
$4.02
Prev Close
$4.00
Day Range
$3.96 – $4.05
52W Range
$2.38 – $7.55
Market Cap
$504.94M
Beta
1.49
EPS (TTM)
$-0.60
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2018-07-25 |
| Shares Out. | 125,450,000 |
| Website | aquestive.com/ ↗ |
| Phone | 19089411900 |
Aquestive Therapeutics Inc is a publicly traded company under the ticker symbol AQST on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
15 analysts (2026-05-01)
📰 Latest News for AQST
Aquestive Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation
Transcript : Aquestive Therapeutics, Inc., Q1 2026 Earnings Call, May 14, 2026
Staar Surgical Posts Upbeat Q1 Results, Joins Cisco, Yeti Holdings And Other Big Stocks Moving Higher On Thursday
Aquestive Therapeutics Q1 2026 Earnings Call: Complete Transcript